Cargando…
Patient-Derived Lung Tumoroids—An Emerging Technology in Drug Development and Precision Medicine
Synthetic 3D multicellular systems derived from patient tumors, or tumoroids, have been developed to complete the cancer research arsenal and overcome the limits of current preclinical models. They aim to represent the molecular and structural heterogeneity of the tumor micro-environment, and its co...
Autores principales: | Lê, Hélène, Seitlinger, Joseph, Lindner, Véronique, Olland, Anne, Falcoz, Pierre-Emmanuel, Benkirane-Jessel, Nadia, Quéméneur, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312903/ https://www.ncbi.nlm.nih.gov/pubmed/35884982 http://dx.doi.org/10.3390/biomedicines10071677 |
Ejemplares similares
-
Vascularization of Patient-Derived Tumoroid from Non-Small-Cell Lung Cancer and Its Microenvironment
por: Seitlinger, Joseph, et al.
Publicado: (2022) -
Patient-Derived Tumoroid for the Prediction of Radiotherapy and Chemotherapy Responses in Non-Small-Cell Lung Cancer
por: Nounsi, Anasse, et al.
Publicado: (2023) -
In vitro vascularized immunocompetent patient-derived model to test cancer therapies
por: Lê, Hélène, et al.
Publicado: (2023) -
Establishment and characterization of canine mammary tumoroids for translational research
por: Raffo-Romero, Antonella, et al.
Publicado: (2023) -
Donors in lung transplantation: does age matter?
por: Ponte, Charlotte, et al.
Publicado: (2023)